Eli Lilly and Co (LLY)
23 Jan 2019
SEOUL, Jan 23 Round-up of South Korean financial markets:
Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and will no longer be prescribed, driving the drugmaker's shares down nearly 3 percent.
Jan 18 Eli Lilly and Co said on Friday its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial testing the therapy in patients with advanced or metastatic soft tissue sarcoma.
Jan 11 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday: ** Twenty-First Century Fox said it does not plan to bid for any of the regional sports networks that Walt Disney Co may need to sell to win U.S. Justice Department's approval for its purchase of Fox's film and TV assets. ** Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, but it plans to remain on the sideli
NEW YORK, Jan 11 (LPC) - Bankers are diagnosing another robust year for US healthcare lending. The first two big loans of 2019 are financing the acquisitions of pharmaceutical companies, including the largest ever tie-up in the sector, and more are expected.
PARIS Pharmaceutical group Eli Lilly said on Tuesday it will cut 250 jobs at its factory located near Strasbourg in Eastern France.
PARIS, Jan 8 Pharmaceutical group Eli Lilly said on Tuesday it will cut 250 jobs at its factory located near Strasbourg in Eastern France.
Eli Lilly said on Monday it will buy Loxo Oncology Inc for $8 billion, an expensive bet on a pipeline of cancer drugs that target rare genetic mutations and the biggest acquisition in the drugmaker's 143-year history. The price represents a 68 percent premium to Loxo's Friday share price close, which some Wall Street analysts said was high for a company with only one drug on the market that it shares with a partner. | Video
Jan 7 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:
Jan 7 Eli Lilly and Co said on Monday it would buy Loxo Oncology Inc for about $8 billion in cash.